Company / Operating Margin
NewAmsterdam Pharma Co N.V. Operating Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-1002.9%
FY2025
5-year range
-1298.6% / -3.5%
FY2022-FY2025
Trend
-159.2%
vs FY2024
Sector context
#119 of 136
Health Care
What the data says
NewAmsterdam Pharma Co N.V.'s operating margin of -1002.9% is lower than 87% of companies in the Health Care sector (FY2025). Improved from -1298.6% to -1002.9% over the past 2 years.
Based on SEC 10-K filings.
-1002.9% in FY2025 with a 3-year CAGR of -999.4%.
Improved from -1298.6% to -1002.9% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -999.4pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 136This company -1002.9% Sector average -778.9%
▼
-28.8% below sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 159.2% year-over-year.
- Currently 224.0pp below the Health Care sector average.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1002.9% | -159.2% |
| FY2024 | -386.9% | +70.2% |
| FY2023 | -1298.6% | -37390.5% |
| FY2022 | -3.5% | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026